Elimination of Aspergillus infection in allogeneic stem cell transplant recipients with long-term itraconazole prophylaxis:: prevention is better than treatment

被引：8
|
作者：
Winston, DJ [1 ]
Emmanouilides, C [1 ]
Bartoni, K [1 ]
Schiller, GJ [1 ]
Paquette, R [1 ]
Territo, MC [1 ]
机构：
[1] Univ Calif Los Angeles, Med Ctr, Dept Med, Div Hematol Oncol,Stem Cell Transplant Program, Los Angeles, CA 90095 USA
来源：
BLOOD | 2004年 / 104卷 / 05期
关键词：
D O I：
10.1182/blood-2004-03-1025
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：1581 / 1581
页数：1
相关论文
共 50 条
  • [1] Elimination of aspergillus as a significant pathogen in an allogeneic hematopoietic stem cell transplant program after introduction of routine long-term itraconazole prophylaxis.
    Winston, DJ
    Emmanouilides, C
    Bartoni, K
    Schiller, GJ
    Paquette, R
    Territo, MC
    [J]. BLOOD, 2003, 102 (11) : 196A - 196A
  • [2] Itraconazole prophylaxis in paediatric stem cell transplant recipients
    Grigull, L
    Kuehlke, O
    Beilken, A
    Schmid, H
    Schrappe, M
    Sander, A
    Linderkamp, C
    Rehe, K
    Book, M
    Welte, K
    [J]. BONE MARROW TRANSPLANTATION, 2005, 35 : S180 - S180
  • [3] Intravenous and oral itraconazole versus intravenous and oral fluconazole for long-term antifungal prophylaxis in allogeneic hematopoietic stem-cell transplant recipients - A multicenter, randomized trial
    Winston, DJ
    Maziarz, RT
    Chandrasekar, PH
    Lazarus, HM
    Goldman, M
    Blumer, JL
    Leitz, GJ
    Territo, MC
    [J]. ANNALS OF INTERNAL MEDICINE, 2003, 138 (09) : 705 - 713
  • [4] Long-Term Analysis of Resilience of the Oral Microbiome in Allogeneic Stem Cell Transplant Recipients
    Laheij, Alexa M. G. A.
    Rozema, Frederik R.
    Brennan, Michael T.
    von Bultzingslowen, Inger
    van Leeuwen, Stephanie J. M.
    Potting, Carin
    Huysmans, Marie-Charlotte D. N. J. M.
    Hazenberg, Mette D.
    Brandt, Bernd W.
    Zaura, Egija
    Buijs, Mark J.
    de Soet, Johannes J.
    Blijlevens, Nicole N. M.
    Raber-Durlacher, Judith E.
    [J]. MICROORGANISMS, 2022, 10 (04)
  • [5] Long-term immunity to poliovirus after vaccination of allogeneic stem cell transplant recipients
    P Ljungman
    J Aschan
    B Gustafsson
    I Lewensohn-Fuchs
    J Winiarski
    O Ringdén
    [J]. Bone Marrow Transplantation, 2004, 34 : 1067 - 1069
  • [6] Long-term immunity to poliovirus after vaccination of allogeneic stem cell transplant recipients
    Ljungman, P
    Aschan, J
    Gustafsson, B
    Lewensohn-Fuchs, I
    Winiarski, J
    Ringdén, O
    [J]. BONE MARROW TRANSPLANTATION, 2004, 34 (12) : 1067 - 1069
  • [7] Long-term survival in allogeneic bone marrow transplant recipients following acyclovir prophylaxis for CMV infection
    Prentice, HG
    Gluckman, E
    Powles, RL
    Ljungman, P
    Milpied, NJ
    Camara, R
    Mandelli, F
    Kho, P
    Kennedy, L
    Bell, AR
    [J]. BONE MARROW TRANSPLANTATION, 1997, 19 (02) : 129 - 133
  • [8] Long-term survival in allogeneic bone marrow transplant recipients following acyclovir prophylaxis for CMV infection
    HG Prentice
    E Gluckman
    RL Powles
    P Ljungman
    NJ Milpied
    R Camara
    F Mandelli
    P Kho
    L Kennedy
    AR Bell
    [J]. Bone Marrow Transplantation, 1997, 19 : 129 - 133
  • [9] Breakthrough disseminated Aspergillus ustus infection in allogeneic hematopoietic stem cell transplant recipients receiving voriconazole or caspofungin prophylaxis
    Pavie, J
    Lacroix, C
    Hermoso, DG
    Robin, M
    Ferry, C
    Bergeron, A
    Feuilhade, M
    Dromer, F
    Gluckman, E
    Molina, JM
    Ribaud, P
    [J]. JOURNAL OF CLINICAL MICROBIOLOGY, 2005, 43 (09) : 4902 - 4904
  • [10] Better microvascular function on long-term treatment with lisinopril than with nifedipine in renal transplant recipients
    Åsberg, A
    Midtvedt, K
    Vassbotn, T
    Hartmann, A
    [J]. NEPHROLOGY DIALYSIS TRANSPLANTATION, 2001, 16 (07) : 1465 - 1470
12345